000306666 001__ 306666
000306666 005__ 20260209103941.0
000306666 0247_ $$2doi$$a10.1097/MOU.0000000000001360
000306666 0247_ $$2pmid$$apmid:41318990
000306666 0247_ $$2ISSN$$a0963-0643
000306666 0247_ $$2ISSN$$a1473-6586
000306666 037__ $$aDKFZ-2025-02659
000306666 041__ $$aEnglish
000306666 082__ $$a610
000306666 1001_ $$aReis, Henning$$b0
000306666 245__ $$aUrachal cancer: a clinical, diagnostic, and therapeutic update.
000306666 260__ $$aLondon$$bLippincott Williams & Wilkins$$c2026
000306666 3367_ $$2DRIVER$$aarticle
000306666 3367_ $$2DataCite$$aOutput Types/Journal article
000306666 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1770629943_645158$$xReview Article
000306666 3367_ $$2BibTeX$$aARTICLE
000306666 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000306666 3367_ $$00$$2EndNote$$aJournal Article
000306666 500__ $$a2026 Mar 1;36(2):155-160
000306666 520__ $$aTo give an overview of the advances in treatment, diagnosis, and epidemiological data of urachal tumors in 2024 and 2025.The update specifically refers to surgical approaches for localized cancers, drug therapy of advanced cancers, diagnostic criteria and consensus recommendations, diagnostic approaches, and epidemiological data.Recommendations for partial cystectomy (if feasible) in localized urachal adenocarcinomas helps to standardize therapeutic approaches. In addition, current clinical trial results and running studies will help to personalize treatment decisions in advanced disease. The ISUP Dublin consensus recommendations will facilitate the diagnostic process and research, as will the summarized, unbiased epidemiological data.
000306666 536__ $$0G:(DE-HGF)POF4-899$$a899 - ohne Topic (POF4-899)$$cPOF4-899$$fPOF IV$$x0
000306666 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000306666 650_7 $$2Other$$aupdate
000306666 650_7 $$2Other$$aurachal cancer
000306666 650_7 $$2Other$$aurachal tumors
000306666 7001_ $$0P:(DE-HGF)0$$aSzarvas, Tibor$$b1
000306666 7001_ $$aPaner, Gladell P$$b2
000306666 773__ $$0PERI:(DE-600)2026970-5$$a10.1097/MOU.0000000000001360$$n2$$p155-160$$tCurrent opinion in urology$$v36$$x0963-0643$$y2026
000306666 909CO $$ooai:inrepo02.dkfz.de:306666$$pVDB
000306666 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000306666 9131_ $$0G:(DE-HGF)POF4-899$$1G:(DE-HGF)POF4-890$$2G:(DE-HGF)POF4-800$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bProgrammungebundene Forschung$$lohne Programm$$vohne Topic$$x0
000306666 9141_ $$y2025
000306666 915__ $$0StatID:(DE-HGF)0410$$2StatID$$aAllianz-Lizenz$$d2025-01-02$$wger
000306666 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2025-01-02
000306666 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2025-01-02
000306666 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2025-01-02
000306666 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2025-01-02
000306666 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2025-01-02
000306666 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2025-01-02
000306666 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2025-01-02
000306666 9201_ $$0I:(DE-He78)ED01-20160331$$kED01$$lDKTK Koordinierungsstelle Essen/Düsseldorf$$x0
000306666 980__ $$ajournal
000306666 980__ $$aVDB
000306666 980__ $$aI:(DE-He78)ED01-20160331
000306666 980__ $$aUNRESTRICTED